Medical Data Entry - Remote Job

$26 - $31/Hour

Location
New York, NY, USA
Job Type
Contract
Industry
Biotech & Pharmaceuticals
Remote/Onsite
Fully Remote
Experience Required
Not Provided
Education Required
Not Essential
Job Summary

About the Company


Quell Therapeutics Ltd. (“Quell”) is a global leader in the development of engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system. The company has raised $156 million in an oversubscribed Series B financing round, co-led by Jeito Capital, Ridgeback Capital Investments, SV Health Investors, and Fidelity Management & Research Company LLC, with participation from founding investor Syncona.



Job Description

Contact payers to obtain medical claim status and follow up on denials or partial payments.

Obtain payer requirements to ensure timely adjudication of claims.

Verify, adjust, and update Accounts Receivable (A/R) based on correspondence received from insurance companies.

Help facilitate interoffice communication regarding error and denial trends.

Research credit balances and initiate refunds when required.

Document all activities in the customer’s account within the system.

Respond to Accounts Receivable phone inquiries.

Work assigned RBCO reports.

Assist other PACs with questions or collection needs when needed.



Qualifications

High School Diploma or General Education Degree (GED) required.

Demonstrated knowledge of insurance policies, qualifications, and guidelines.

Strong telephone etiquette and effective oral and written communication skills.

Ability to multitask and manage multiple priorities.

Positive and cooperative attitude when working with individuals at all levels of the organization.

Knowledge of the medical field preferred.



Benefits


25 days paid holiday per year

Flexible working environment

Private medical insurance for employees and their families

Life assurance (about 4× base salary)

Group personal pension plan (around 6% employer contribution)

Annual performance bonusHealth cash plan for medical expenses

Company Summary
Quell Therapeutics Ltd (“Quell”), the world leader in the development of engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announced it has raised $156 million in an oversubscribed Series B financing. The financing round was co-led by Jeito Capital, Ridgeback Capital Investments, SV Health Investors and Fidelity Management & Research Company LLC with participation from founding investor Syncona. New investors include British Patient Capital through its Future Fund: Breakthrough program, Janus Henderson Investors, Monashee Investment Management, Point72 and funds managed by Tekla Capital Management LLC.
Apply
Upload Your CV
Please upload a PDF or Doc file. Max 3mb in size.
Your Details
Job Managed With